Health Canada announced on December 23, 2021 that the coming into force of the Patented Medicines Regulations has been delayed for another 6 months to July 1, 2022. As a result, implementation of the New PMPRB Guidelines (which in part rely on the amended Regulations) are also delayed until July 2022.  Further information can be found on the Health Canada website.

Given recent court decisions, there is some doubt as to whether the New Guidelines can be implemented without significant changes and further consultations. PDCI is hosting a webinar January 25 (see below) that will provide an overview of the impact and implications of the delayed Regulations and Guidelines.  

Form-2 Filing Reminder
PMPRB Form 2 filings are due January 30, 2022. As the current Regulations remain in force, the January filing requirements will be as per the current Regulations and Guidelines, including reporting sales data by class of customer and province, and filing Block 5 information based on the PMPRB7 reference basket.

PDCI is prepared for the upcoming semi-annual filing and continues to provide clients ongoing support through these uncertain times. Please contact Jennifer Mathews or Mevin Mathew for more information on PDCI’s Form-2 filing services.
 
January PMPRB Webinar: Save the date!
PDCI will be hosting a webinar on January 25, 2022 from 11:00 a.m. to 12:30 p.m. (ET).  The webinar will feature PDCI pricing experts joined by a leading IP lawyer and a leading government affairs expert. Further details will be released in the coming weeks.

Please contact John-Paul Dowson, Director of Strategic Consulting & Policy Research at jp.dowson@pdci.ca for any questions or further information.

For Form 2 information you may contact Jennifer Mathews at Jennifer.Mathews@pdci.ca or Mevin Mathew at Mevin.Mathew@pdci.ca.